Skip to main contentSkip to navigation
Sirius Investors

TRXPF Stock: Torii Pharmaceutical Co., Ltd. Stock Price, Analysis & Insights

Get live TRXPF stock price $24.57, comprehensive Torii Pharmaceutical Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time TRXPF stock data and investment insights.

24.57
0.00%Today
TRXPFTorii Pharmaceutical Co., Ltd. • Other OTC • Healthcare
Market Cap
690.70M
Volume
100
52W High
24.57
52W Low
24.57

Loading chart data...

Torii Pharmaceutical Co., Ltd. (TRXPF) Overview

Torii Pharmaceutical Co., Ltd. (TRXPF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, TRXPF trades at $24.57 with a market capitalization of 690.70M . Over the past 52 weeks, TRXPF has traded between $24.57 and $24.57 , with the current price positioned at approximately NaN% of...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 690.70M
  • Current price: $24.57
  • 52-week range: $24.57 - $24.57
  • P/E ratio: 25.86

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Torii Pharmaceutical Co., Ltd., a Tokyo-based Japanese firm established in 1872, specializes in the development and commercialization of a variety of pharmaceutical products. Its therapeutic portfolio features Riona, a medication addressing hyperphos...

Company Information

CEO
Goichi Matsuda
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
583

Contact Information

Address
Torii Nihonbashi Bldg.
Country
JP

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 25.9)

Lower volatility stock (Beta: 0.33) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Torii Pharmaceutical Co., Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Torii Pharmaceutical Co., Ltd.
  • Investors should consider how Torii Pharmaceutical Co., Ltd. fits within their overall portfolio allocation

Market Cap

690.70M

P/E Ratio (TTM)

25.86

Beta

0.33

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.